Delivery Order SPE2DB20D7061-SPE2DB24FSPX9
Award Date
9/20/24
Potential Completion Date
9/23/24
Potential Value
$51K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,731.44 firm fixed-price delivery order is for the supply of 4565520786 ABRYSVO VIAL WITH DILUENT SYRGS, a medical supply product. The contract has an ultimate completion date of August 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of "ABRYSVO VIAL WITH DILUENT SYRGS" medical supplies. The order has a firm fixed price of $30,357.37 and a completion date of September 12, 2024. Amerisourcebergen, through its Corporate Office Division, is a key vendor for the DLA, holding an Indefinite Delivery Contract (IDC) valued up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,342.50 firm-fixed-price contract is for the delivery of "ABRYSVO VIAL WITH DILUENT SYRGS", a medical product, with a completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $2,425.72 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ABRYSVO Vial with Diluent Syringes. The contract has an ultimate completion date of September 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of ABRYSVO VIAL WITH DILUENTS, a pharmaceutical product, with a completion date of January 26, 2024 and a potential value of $8,844.44. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
This firm-fixed-price delivery order, valued at $11,032.08, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the delivery of ABRYSVO VIAL WITH DILUENTS, a pharmaceutical product, by June 7, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $10,482.55 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565931324 ABRYSVO VIAL WITH DILUENT SYRGS. This product is a medical supply used to support military treatment programs and facilities worldwide. The contract has a firm fixed price and an ultimate completion date of September 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with an ultimate completion date of November 25, 2024 and a ceiling value of $42,723.83. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,683.55, is for the delivery of ABRYSVO vials with diluent syringes, a medical product. The contract has a firm fixed price and an ultimate completion date of April 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $5,559.60 contract is for the supply of ABRYSVO VIAL WITH DILUENTS, a pharmaceutical product. This award does not have a set-aside designation. The contract was awarded on August 1, 2024 with a completion date of August 2, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with...